Since the induction of TL1A gene expression seems to be restricted to stimulation by FcγR signaling and/or enteric bacteria [7], [40], [41], blockage of TL1A might have therapeutic benefit in IBD patients without markedly increasing the susceptibility to infection. Here, FCGR2A is linked to infection.